Back
Vanguard Growth Index Fund ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
66
VUG
Vanguard Growth Index Fund ETF
Last Price:
$482.88
Seasonality Move:
0.81%
Buy
67
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.52
Seasonality Move:
-9.01%
Buy
66
Vanguard Growth Index Fund ETF (VUG)
is a Buy
Is Vanguard Growth Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Growth Index Fund ETF [VUG] share price is $485.26. The Score for VUG is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
VUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VUG Stock Price Chart
What is Vanguard Growth Index Fund ETF's stock price today?
-
The Vanguard Growth Index Fund ETF share price today is $485.26The current trend is moderately bullish and VUG is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $113.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
VUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 74.34 | Buy |
| Relative Strength Index (14 RSI): | 46.86 | Sell |
| Chaikin Money Flow: | -570249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (478.16 - 494.44) | Sell |
| Bollinger Bands (100): | (460.4 - 490.08) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 59.45 | Buy |
| Chaikin Money Flow: | -357754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.81 - 108.61) | Buy |
| Bollinger Bands (100): | (93.91 - 107.83) | Buy |
VUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 491.94 | Sell |
| 20-day SMA: | 485.3 | Sell |
| 50-day SMA: | 486.76 | Sell |
| 200-day SMA: | 437.54 | Buy |
| 8-day EMA: | 488.83 | Sell |
| 20-day EMA: | 439.6 | Buy |
| 50-day EMA: | 292.94 | Buy |
| 200-day EMA: | 99.9 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.1 | Buy |
| 20-day SMA: | 105.06 | Buy |
| 50-day SMA: | 105.14 | Buy |
| 200-day SMA: | 81.74 | Buy |
| 8-day EMA: | 108.55 | Buy |
| 20-day EMA: | 106.16 | Buy |
| 50-day EMA: | 103.93 | Buy |
| 200-day EMA: | 86.65 | Buy |
Vanguard Growth Index Fund ETF Earnings Growth & VUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Vanguard Growth Index Fund ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||